SEC Form 4 · accession 0001209191-18-026950

GLOBUS MEDICAL INC · GMED

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

David C Paul

Officer — Executive Chairman · Director · 10% Owner

Period of report

Apr 26, 2018

Accepted (ET)

Apr 30, 2018 · 8:59 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001237831

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Apr 26, 2018	M	18,461	$4.88	A	1,096,461	D
Class A Common Stock^F2	Apr 26, 2018	S	18,461	$51.8068	D	1,078,000	D
Class A Common Stock	Apr 26, 2018	M	18,461	$11.8625	A	1,096,461	D
Class A Common Stock^F2	Apr 26, 2018	S	18,461	$51.8068	D	1,078,000	D
Class A Common Stock	Apr 26, 2018	M	18,461	$10.66	A	1,096,461	D
Class A Common Stock^F2	Apr 26, 2018	S	18,461	$51.8068	D	1,078,000	D
Class A Common Stock	Apr 26, 2018	M	15,000	$15.34	A	1,093,000	D
Class A Common Stock^F2	Apr 26, 2018	S	15,000	$51.8068	D	1,078,000	D
Class A Common Stock	Apr 26, 2018	M	48,000	$13.04	A	1,126,000	D
Class A Common Stock^F2	Apr 26, 2018	S	48,000	$51.8068	D	1,078,000	D
Class A Common Stock	Apr 26, 2018	M	60,000	$23.95	A	1,138,000	D
Class A Common Stock^F2	Apr 26, 2018	S	60,000	$51.8068	D	1,078,000	D
Class A Common Stock	Apr 26, 2018	M	98,958	$24.10	A	1,176,958	D
Class A Common Stock^F2	Apr 26, 2018	S	98,958	$51.8068	D	1,078,000	D
Class A Common Stock	Apr 26, 2018	M	40,625	$25.52	A	1,118,625	D
Class A Common Stock^F2	Apr 26, 2018	S	40,625	$51.8068	D	1,078,000	D
Class A Common Stock	Apr 26, 2018	M	43,750	$26.27	A	1,121,750	D
Class A Common Stock^F2	Apr 26, 2018	S	43,750	$51.8068	D	1,078,000	D
Class A Common Stock^F2	Apr 26, 2018	S	363,284	$51.8068	D	714,716	D
Class A Common Stock^F3	Apr 27, 2018	S	29,066	$51.7831	D	685,650	D
Class A Common Stock^F4	Apr 30, 2018	S	72,938	$51.8053	D	612,712	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy Class A Common Stock)^F5	$4.88	Apr 26, 2018	M	18,461	D	—	Aug 6, 2019	Class A Common Stock	18,461	0	D
Stock Option (Right to Buy Class A Common Stock)^F6	$11.8625	Apr 26, 2018	M	18,461	D	—	Jun 16, 2020	Class A Common Stock	18,461	0	D
Stock Option (Right to Buy Class A Common Stock)^F7	$10.66	Apr 26, 2018	M	18,461	D	—	Oct 27, 2021	Class A Common Stock	18,461	0	D
Stock Option (Right to Buy Class A Common Stock)^F8	$15.34	Apr 26, 2018	M	15,000	D	—	Aug 29, 2022	Class A Common Stock	15,000	0	D
Stock Option (Right to Buy Class A Common Stock)^F9	$13.04	Apr 26, 2018	M	48,000	D	—	Jan 24, 2023	Class A Common Stock	48,000	0	D
Stock Option (Right to Buy Class A Common Stock)^F10	$23.95	Apr 26, 2018	M	60,000	D	—	Jan 23, 2024	Class A Common Stock	60,000	0	D
Stock Option (Right to Buy Class A Common Stock)^F11	$24.10	Apr 26, 2018	M	98,958	D	—	Jan 20, 2025	Class A Common Stock	98,958	26,042	D
Stock Option (Right to Buy Class A Common Stock)^F12	$25.52	Apr 26, 2018	M	40,625	D	—	Jan 25, 2026	Class A Common Stock	40,625	34,375	D
Stock Option (Right to Buy Class A Common Stock)^F13	$26.27	Apr 26, 2018	M	43,750	D	—	Jan 30, 2027	Class A Common Stock	43,750	106,250	D

Explanation of responses

F1This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
F10These options were granted on January 23, 2014, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F11These options were granted on January 20, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F12These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F13These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $51.8558, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $51.935, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
F5These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F6These options were granted on June 16, 2010, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2011, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F7These options were granted on October 27, 2011, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F8These options were granted on August 29, 2012, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F9These options were granted on January 24, 2013, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.